[YMAB] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
08-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -1,171.07%
YoY- 82.08%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 19,931 20,251 10,486 5,383 0 0 0 -
PBT -6,469 -6,390 -28,068 33,413 -26,179 -15,934 -7,483 -2.39%
Tax 160 -1,293 373 338 0 -19 -7,479 -
NP -6,629 -5,097 -28,441 33,413 -26,179 -15,934 -7,483 -1.99%
Tax Rate - - - -1.01% - - - -
Total Cost 26,560 25,348 38,927 -28,030 26,179 15,934 7,483 23.48%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -33.26 -25.17 -271.23 620.71 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.15 -0.12 -0.65 0.80 -0.66 -0.47 -0.22 -6.17%
EPS Diluted -0.15 -0.12 -0.65 0.75 -0.66 -0.47 -0.22 -6.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.